These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26469867)

  • 1. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
    Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
    Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J; Bengtsson J
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.
    Wienzek-Lischka S; König IR; Papenkort EM; Hackstein H; Santoso S; Sachs UJ; Bein G
    Transfusion; 2017 Mar; 57(3):533-540. PubMed ID: 28019029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
    de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
    Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypes.
    Ahlen MT; Heide G; Husebekk A; Skogen B; Kjeldsen-Kragh J; Stuge TB
    Scand J Immunol; 2020 Jul; 92(1):e12890. PubMed ID: 32299122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia.
    Matusiak K; Patriquin CJ; Deniz S; Dzaja N; Smith JW; Wang G; Nazy I; Kelton JG; Arnold DM
    Transfusion; 2022 Nov; 62(11):2213-2222. PubMed ID: 36239096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.
    Yougbaré I; Lang S; Yang H; Chen P; Zhao X; Tai WS; Zdravic D; Vadasz B; Li C; Piran S; Marshall A; Zhu G; Tiller H; Killie MK; Boyd S; Leong-Poi H; Wen XY; Skogen B; Adamson SL; Freedman J; Ni H
    J Clin Invest; 2015 Apr; 125(4):1545-56. PubMed ID: 25774504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in fetal and neonatal alloimmune thrombocytopenia.
    Bussel JB; Vander Haar EL; Berkowitz RL
    Am J Obstet Gynecol; 2021 Aug; 225(2):120-127. PubMed ID: 33839095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.
    Loewenthal R; Rosenberg N; Kalt R; Dardik R; Landau M; Yahalom V; Avishai O; Frenkel O; Gazit E; Steinberg DM; Lipitz S; Salomon O
    Transfusion; 2013 Feb; 53(2):344-52. PubMed ID: 22671039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foetal and neonatal alloimmune thrombocytopenia - The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome.
    Kjeldsen-Kragh J; Ahlen MT
    Transfus Apher Sci; 2020 Feb; 59(1):102707. PubMed ID: 31919011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracranial hemorrhages in neonates born from 32 weeks of gestation-low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register-based study.
    Refsum E; Håkansson S; Mörtberg A; Wikman A; Westgren M
    Transfusion; 2018 Jan; 58(1):223-231. PubMed ID: 29119564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe intracranial haemorrhage in neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1b: Case report and literature review.
    Tomac G; Gojčeta K; Grizelj R; Coen Herak D; Ostojić SB; Golubić Ćepulić B
    Transfus Med; 2022 Aug; 32(4):269-275. PubMed ID: 35730350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
    Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
    Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune Thrombocytopenia.
    Santoso S; Wihadmadyatami H; Bakchoul T; Werth S; Al-Fakhri N; Bein G; Kiefel V; Zhu J; Newman PJ; Bayat B; Sachs UJ
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1517-24. PubMed ID: 27283740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia.
    Sachs UJ; Wienzek-Lischka S; Duong Y; Qiu D; Hinrichs W; Cooper N; Santoso S; Bayat B; Bein G
    Br J Haematol; 2020 May; 189(4):751-759. PubMed ID: 31997312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia.
    Bertrand G; Drame M; Martageix C; Kaplan C
    Blood; 2011 Mar; 117(11):3209-13. PubMed ID: 21239703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia.
    Sainio S; Javela K; Tuimala J; Haimila K
    Br J Haematol; 2017 Jan; 176(1):111-117. PubMed ID: 27748520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.
    de Vos TW; Winkelhorst D; Árnadóttir V; van der Bom JG; Canals Surís C; Caram-Deelder C; Deschmann E; Haysom HE; Hverven HBC; Lozar Krivec J; McQuilten ZK; Muñiz-Diaz E; Nogués N; Oepkes D; Porcelijn L; van der Schoot CE; Saxonhouse M; Sola-Visner M; Tiblad E; Tiller H; Wood EM; Young V; Železnik M; de Haas M; Lopriore E
    Lancet Haematol; 2022 Nov; 9(11):e844-e853. PubMed ID: 36108655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.
    Kjær M; Geisen C; Akkök ÇA; Wikman A; Sachs U; Bussel JB; Nielsen K; Walles K; Curtis BR; Vidarsson G; Järås K; Skogen B
    Transfus Apher Sci; 2020 Feb; 59(1):102712. PubMed ID: 31948915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taking a wider view on fetal/neonatal alloimmune thrombocytopenia.
    Bonstein L; Haddad N
    Thromb Res; 2017 Mar; 151 Suppl 1():S100-S102. PubMed ID: 28262226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.